Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study.
Szabó BG, Czél E, Nagy I, Korózs D, Petrik B, Marosi B, Gáspár Z, Rajmon M, Di Giovanni M, Vályi-Nagy I, Sinkó J, Lakatos B, Bobek I. Szabó BG, et al. Among authors: sinko j. Antibiotics (Basel). 2023 Jul 17;12(7):1196. doi: 10.3390/antibiotics12071196. Antibiotics (Basel). 2023. PMID: 37508292 Free PMC article.
Optimizing management of invasive mould diseases.
Agrawal S, Hope W, Sinkó J, Kibbler C. Agrawal S, et al. Among authors: sinko j. J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i45-53. doi: 10.1093/jac/dkq441. J Antimicrob Chemother. 2011. PMID: 21177403 Review.
Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.
Lakatos B, Szabo BG, Bobek I, Gopcsa L, Beko G, Kiss-Dala N, Petrik B, Gaspar Z, Farkas BF, Sinko J, Remenyi P, Szlavik J, Valyi-Nagy I. Lakatos B, et al. Among authors: sinko j. Acta Microbiol Immunol Hung. 2021 Aug 6. doi: 10.1556/030.2021.01526. Online ahead of print. Acta Microbiol Immunol Hung. 2021. PMID: 34370690
Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome.
Gopcsa L, Bobek I, Bekő G, Lakatos B, Molnár E, Réti M, Reményi P, Sinkó J, Szlávik J, Tatai G, Vályi-Nagy I. Gopcsa L, et al. Among authors: sinko j. Acta Microbiol Immunol Hung. 2021 Nov 19. doi: 10.1556/030.2021.01620. Online ahead of print. Acta Microbiol Immunol Hung. 2021. PMID: 34797216
Simultaneous effective treatment of critical COVID-19 disease and newly diagnosed high-risk multiple myeloma with thalidomide, methylprednisolone, tocilizumab and baricitinib: is it clinically feasible?
Szabo BG, Lorinczi C, Szanka J, Lakatos B, Sinko J, Szlavik J, Mikala G. Szabo BG, et al. Among authors: sinko j. Minerva Med. 2021 Dec 3. doi: 10.23736/S0026-4806.20.07050-0. Online ahead of print. Minerva Med. 2021. PMID: 34856779 Free article. No abstract available.
Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study.
Lakatos B, Szabó BG, Bobek I, Kiss-Dala N, Gáspár Z, Riczu A, Petrik B, Farkas BF, Sebestyén G, Gopcsa L, Bekő G, Sinkó J, Reményi P, Szlávik J, Mathiász D, Vályi-Nagy I. Lakatos B, et al. Among authors: sinko j. Int J Infect Dis. 2022 Dec;125:233-240. doi: 10.1016/j.ijid.2022.10.037. Epub 2022 Oct 31. Int J Infect Dis. 2022. PMID: 36328291 Free PMC article.
67 results